Summary Basis for Regulatory Action

First Page		Document Content
Orphan drugs Transfusion medicine Idiopathic thrombocytopenic purpura Romiplostim Thrombocytopenia Intravenous immunoglobulin Rho(D) immune globulin Eltrombopag Platelet Medicine Biology Blood		Summary Basis for Regulatory Action Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 331,47 KB Share Document on Facebook

	Important Medical Information Immune Thrombocytopenia, ITP itpinternational.org This person has ITP, Immune Thrombocytopenia (formerly known as: Idiopathic Thrombocytopenic Purpura) DocID: 1giFn - View Document
	What is ITP? –parent leaflet Introduction This leaflet explains about immune thrombocytopenic purpura (ITP), which is a blood disorder affecting the platelets. It also explains what to expect when your child is diagnos DocID: 1ggQz - View Document
	About the Platelet Disorder Support Association The Platelet Disorder Support Association (PDSA), founded in August 1998, is the nation’s foremost non-profit corporation to provide information and support and to encour DocID: 1gc3y - View Document
	TO BE PRINTED ON LOCAL HEADED PAPER United Kingdom Childhood ITP Registry DocID: 1g9z9 - View Document
	The UK Paediatric ITP Working Party UK Paediatric Chronic ITP Registry Synopsis DocID: 1g9vS - View Document